Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease

References

• Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob. Control13(4), 388–395 (2004).
   PubMed Web of Science ®Google Scholar
• Jha P, Chaloupka FJ, Moore J et al. Tobacco Addiction. In: Disease Control Priorities in Developing Countries. Jamison DT, Bregman JG, Measham A (Ed.). Oxford University Press, World Bank, NY, USA, 869–885 (2006).
   Google Scholar
• Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet364(9438), 937–952 (2004).
   PubMed Web of Science ®Google Scholar
• World Health Organisation. MPOWER. WHO Report on the Global Tobacco Epidemic. World Health Organisation, Geneva (2008).
   Google Scholar
• Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. Br. Med. J.309(6959), 901–911 (1994).
   PubMed Web of Science ®Google Scholar
• Hammond EC, Garfinkel L. Coronary heart disease, stroke, and aortic aneurysm. Arch. Environ. Health19(2), 167–182 (1969).
   PubMed Web of Science ®Google Scholar
• US Department of Health Education and Welfare. Smoking and health: report of the Advisory Committee to the Surgeon General of the Public Health Service. In: PHS Publication (Eds). US Department of Health, Education and Welfare Public Health Service, DC, USA (1964).
   Google Scholar
• Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog. Cardiovasc. Dis.46(1), 91–111 (2003).
   PubMed Web of Science ®Google Scholar
• Teo KK, Ounpuu S, Hawken S et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case–control study. Lancet368(9536), 647–658 (2006).
   PubMed Web of Science ®Google Scholar
• Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog. Cardiovasc. Dis.46(1), 11–29 (2003).
   PubMed Web of Science ®Google Scholar
• Metz L, Waters DD. Implications of cigarette smoking for the management of patients with acute coronary syndromes. Prog. Cardiovasc. Dis.46(1), 1–9 (2003).
   PubMedGoogle Scholar
• Nakamura K, Barzi F, Lam T et al. Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the Asia-Pacific Region. Stroke39(6), 1694–1702 (2008).
   PubMedGoogle Scholar
• Willett WC, Green A, Stampfer MJ et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N. Engl. J. Med.317(21), 1303–1309 (1987).
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Hall SM, Herning RI et al. Smokers of low-yield cigarettes do not consume less nicotine. N. Engl. J. Med.309(3), 139–142 (1983).
   PubMed Web of Science ®Google Scholar
• Jacobs EJ, Thun MJ, Apicella LF. Cigar smoking and death from coronary heart disease in a prospective study of US men. Arch. Internal Med.159(20), 2413–2418 (1999).
   PubMedGoogle Scholar
• Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N. Engl. J. Med.340(23), 1773–1780 (1999).
   PubMed Web of Science ®Google Scholar
• Bjartveit K, Tverdal A. Health consequences of smoking 1–4 cigarettes per day. Tob. Control,14, 315–320 (2005).
   PubMed Web of Science ®Google Scholar
• Negri E, La Vecchia C, Nobili A, D’Avanzo B, Bechi S. Cigarette smoking and acute myocardial infarction. A case–control study from the GISSI-2 trial. GISSI-EFRIM Investigators. Eur. J. Epidemiol.10(4), 361–366 (1994).
   PubMed Web of Science ®Google Scholar
• Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. Br. Med. J.315(7114), 973–980 (1997).
   PubMed Web of Science ®Google Scholar
• Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation91(6), 1749–1756 (1995).
   PubMed Web of Science ®Google Scholar
• Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR, Jr. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N. Engl. J. Med.336(11), 755–761 (1997).
   PubMed Web of Science ®Google Scholar
• Price JF, Mowbray PI, Lee AJ et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur. Heart J.20(5), 344–353 (1999).
   PubMed Web of Science ®Google Scholar
• Kannel WB, Shurtleff D. The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics28(2), 61–68 (1973).
   PubMed Web of Science ®Google Scholar
• Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA295(5), 547–553 (2006).
   PubMed Web of Science ®Google Scholar
• Hooi JD, Kester AD, Stoffers HE et al. Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am. J. Epidemiol.153(7), 666–672 (2001).
   PubMed Web of Science ®Google Scholar
• Hooi JD, Stoffers HE, Knottnerus JA, van Ree JW. The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence. Br. J. Gen. Pract.49(438), 49–55 (1999).
   PubMedGoogle Scholar
• Hooi JD, Stoffers HE, Kester AD et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand. J. Prim. Health Care16(3), 177–182 (1998).
   PubMed Web of Science ®Google Scholar
• Bendermacher BLW, Willigendael EM, Teijink JAW, Prins MH. Medical management of peripheral arterial disease. J. Thromb. Haemost.3(8), 1628–1637 (2005).
   PubMed Web of Science ®Google Scholar
• Willigendael EM, Teijink JAW, Bartelink M-L et al. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J. Vasc. Surg.42(1), 67–74 (2005).
   PubMed Web of Science ®Google Scholar
• Kazmers A, Kohler TR. Very late survival after vascular surgery. J. Surg. Res.105(2), 109–114 (2002).
   PubMedGoogle Scholar
• Witteman JC, Grobbee DE, Valkenburg HA et al. Cigarette smoking and the development and progression of aortic atherosclerosis. A 9-year population-based follow-up study in wom en. Circulation88(5 Pt 1), 2156–2162 (1993).
   PubMedGoogle Scholar
• Brady AR, Thompson SG, Fowkes FGR et al. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation110(1), 16–21 (2004).
   PubMed Web of Science ®Google Scholar
• Vardulaki KA, Walker NM, Day NE et al. Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br. J. Surg.87(2), 195–200 (2000).
   PubMed Web of Science ®Google Scholar
• Lederle FA, Nelson DB, Joseph AM. Smokers’ relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J. Vasc. Surg.38(2), 329–334 (2003).
   PubMed Web of Science ®Google Scholar
• Iribarren C, Darbinian JA, Go AS et al. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: The Kaiser Multiphasic Health Checkup Cohort Study. Ann. Epidemiol.17, 669–678 (2007).
   PubMed Web of Science ®Google Scholar
• Kurth T, Kase CS, Berger K et al. Smoking and risk of hemorrhagic stroke in women. Stroke34(12), 2792–2795 (2003).
   PubMed Web of Science ®Google Scholar
• Hart CL, Hole DJ, Smith GD. Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. Stroke30(10), 1999–2007 (1999).
   PubMed Web of Science ®Google Scholar
• Colditz GA, Bonita R, Stampfer MJ et al. Cigarette smoking and risk of stroke in middle-aged women. N. Engl. J. Med.318(15), 937–941 (1988).
   PubMed Web of Science ®Google Scholar
• Kelly T, Gu D, Chen J et al. Cigarette smoking and risk of stroke in the Chinese adult population. Stroke39(6), 1688–1693. (2008).
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Adams R, Alberts MJ et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke37(6), 1583–1633 (2006).
   PubMed Web of Science ®Google Scholar
• Haustein K. Tobacco or Health: Physiological and Social Damages Caused by Tobacco Smoking. Springer, Berlin, Germany (2002).
   Google Scholar
• Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol.43(10), 1731–1737 (2004).
   PubMed Web of Science ®Google Scholar
• Benowitz NL. Nicotine Safety and Toxicity. Oxford University Press, NY, USA (1998).
   Google Scholar
• Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science226(4671), 180–182 (1984).
   PubMed Web of Science ®Google Scholar
• Asplund K. Smokeless tobacco and cardiovascular disease. Prog. Cardiovasc. Dis.45(5), 383–394 (2003).
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Porchet H, Sheiner L, Jacob P 3rd. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin. Pharmacol. Ther.44(1), 23–28 (1988).
   PubMed Web of Science ®Google Scholar
• Eliasson M, Lundblad D, Hagg E. Cardiovascular risk factors in young snuff-users and cigarette smokers. J. Intern. Med.230(1), 17–22. (1991).
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J. Am. Coll. Cardiol.29(7), 1422–1431 (1997).
   PubMed Web of Science ®Google Scholar
• FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am. Heart J.115(1 Pt 2), 267–271 (1988).
   PubMed Web of Science ®Google Scholar
• Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med.326(5), 310–318 (1992).
   PubMed Web of Science ®Google Scholar
• Ernst E, Koenig W, Matrai A, Filipiak B, Stieber J. Blood rheology in healthy cigarette smokers. Results from the MONICA project, Augsburg. Arteriosclerosis8(4), 385–388 (1988).
   PubMedGoogle Scholar
• Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA258(9), 1183–1186 (1987).
   PubMed Web of Science ®Google Scholar
• Ernst E. Fibrinogen: its emerging role as a cardiovascular risk factor. Angiology45(2), 87–93 (1994).
   PubMedGoogle Scholar
• Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am. Heart J.115(1 Pt 2), 242–249 (1988).
   PubMed Web of Science ®Google Scholar
• Sambola A, Osende J, Hathcock J et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation107(7), 973–977 (2003).
   PubMed Web of Science ®Google Scholar
• Burke A, Fitzgerald GA. Oxidative stress and smoking-induced vascular injury. Prog. Cardiovasc. Dis.46(1), 79–90 (2003).
   PubMed Web of Science ®Google Scholar
• Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation94(1), 6–9 (1996).
   PubMed Web of Science ®Google Scholar
• Stamatelopoulos KS, Lekakis JP, Papamichael CM et al. Oral administration of ascorbic acid attenuates endothelial dysfunction after short-term cigarette smoking. Int. J. Vitam. Nutr. Res.73(6), 417–422 (2003).
   PubMed Web of Science ®Google Scholar
• Lehr HA, Weyrich AS, Saetzler RK et al. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J. Clin. Invest.99(10), 2358–2364 (1997).
   PubMed Web of Science ®Google Scholar
• Zhang J, Ying X, Lu Q et al. A single high dose of vitamin C counteracts the acute negative effect on microcirculation induced by smoking a cigarette. Microvasc. Res.58(3), 305–311 (1999).
   PubMed Web of Science ®Google Scholar
• Katayama Y, Shige H, Yamamoto A, Hirata F, Yasuda H. Oral vitamin C ameliorates smoking-induced arterial wall stiffness in healthy volunteers. J. Atheroscler. Thromb.11(6), 354–357 (2004).
   PubMedGoogle Scholar
• Stadler N, Eggermann J, Voo S, Kranz A, Waltenberger J. Smoking-induced monocyte dysfunction is reversed by vitamin C supplementation in vivo. Arterioscler. Thromb. Vasc. Biol.27(1), 120–126 (2007).
   PubMedGoogle Scholar
• Duthie GG, Arthur JR, Beattie JA et al. Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease. Ann. NY Acad. Sci.686, 120–129 (1993).
   PubMedGoogle Scholar
• Harats D, Ben-Naim M, Dabach Y et al. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis79(2–3), 245–252 (1989).
   PubMed Web of Science ®Google Scholar
• Barua RS, Ambrose JA, Eales-Reynolds LJ et al. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation104(16), 1905–1910 (2001).
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation88(5 Pt 1), 2149–2155 (1993).
   PubMed Web of Science ®Google Scholar
• Higman DJ, Greenhalgh RM, Powell JT. Smoking impairs endothelium-dependent relaxation of saphenous vein. Br. J. Surg.80(10), 1242–1245 (1993).
   PubMedGoogle Scholar
• Kiowski W, Linder L, Stoschitzky K et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation90(1), 27–34 (1994).
   PubMed Web of Science ®Google Scholar
• Petitti DB, Kipp H. The leukocyte count: associations with intensity of smoking and persistence of effect after quitting. Am. J. Epidemiol.123(1), 89–95 (1986).
   PubMed Web of Science ®Google Scholar
• Lavi S, Prasad A, Yang EH et al. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation115(20), 2621–2627 (2007).
   PubMed Web of Science ®Google Scholar
• Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA254(14), 1932–1937 (1985).
   PubMed Web of Science ®Google Scholar
• Lam TH, Stewart SM, Ho SY et al. Depressive symptoms and smoking among Hong Kong Chinese adolescents. Addiction100(7), 1003–1011 (2005).
   PubMed Web of Science ®Google Scholar
• Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation91(6), 1872–1885 (1995).
   PubMed Web of Science ®Google Scholar
• Waters D, Lesperance J, Gladstone P et al.; CCAIT Study Group. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. Circulation94(4), 614–621 (1996).
   PubMed Web of Science ®Google Scholar
• Howard G, Wagenknecht LE, Burke GL et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA279(2), 119–124 (1998).
   PubMed Web of Science ®Google Scholar
• He J, Vupputuri S, Allen K et al. Passive smoking and the risk of coronary heart disease – a meta-analysis of epidemiologic studies. N. Engl. J. Med.340(12), 920–926 (1999).
   PubMed Web of Science ®Google Scholar
• Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation111(20), 2684–2698 (2005).
   PubMed Web of Science ®Google Scholar
• Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R. Passive smoking as well as active smoking increases the risk of acute stroke. Tob. Control8(2), 156–160 (1999).
   PubMed Web of Science ®Google Scholar
• Donnan GA, McNeil JJ, Adena MA et al. Smoking as a risk factor for cerebral ischaemia. Lancet2(8664), 643–647 (1989).
   PubMed Web of Science ®Google Scholar
• Whincup PH, Gilg JA, Emberson JR et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. Br. Med. J.329(7459), 200–205 (2004).
   PubMedGoogle Scholar
• Iribarren C, Darbinian JA, Klatsky AL, Friedman GD. Cohort study of exposure to environmental tobacco smoke exposure and risk of first ischemic stroke and transient ischemic attack. Neuroepidemiology23, 8–44 (2007).
   Google Scholar
• Wang XL, Raveendran M, Wang J. Genetic influence on cigarette-induced cardiovascular disease. Prog. Cardiovasc. Dis.45(5), 361–382 (2003).
   PubMed Web of Science ®Google Scholar
• Thorgeirsson TE, Geller F, Sulem P et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature452(7187), 638–642 (2008).
   PubMed Web of Science ®Google Scholar
• Lou XY, Ma JZ, Sun D et al. Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European–Americans. Hum. Mol. Genet.16(2), 142–153 (2007).
   PubMed Web of Science ®Google Scholar
• Saccone S, Hinrichs AL, Saccone NL et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet.16(1), 36–49 (2007).
   PubMed Web of Science ®Google Scholar
• Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA290(1), 86–97 (2003).
   PubMed Web of Science ®Google Scholar
• Peters RW, Brooks MM, Todd L, Liebson PR, Wilhelmsen L; The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Smoking cessation and arrhythmic death: the CAST experience. J. Am. Coll. Cardiol.26(5), 1287–1292 (1995).
   PubMedGoogle Scholar
• Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N. Engl. J. Med.314(5), 271–275 (1986).
   PubMed Web of Science ®Google Scholar
• Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med. Scand.221(3), 253–260 (1987).
   PubMed Web of Science ®Google Scholar
• Robbins AS, Manson JE, Lee IM, Satterfield S, Hennekens CH. Cigarette smoking and stroke in a cohort of U.S. male physicians. Ann. Intern. Med.120(6), 458–462 (1994).
   PubMed Web of Science ®Google Scholar
• Kenfield S, Stampfer M, Rosner B, Colditz G. Smoking and smoking cessation in relation to mortality in women. JAMA299, 2037–2047(2008).
   PubMed Web of Science ®Google Scholar
• Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation96(4), 1089–1096 (1997).
   PubMed Web of Science ®Google Scholar
• Hunter KA, Garlick PJ, Broom I, Anderson SE, McNurlan MA. Effects of smoking and abstention from smoking on fibrinogen synthesis in humans. Clin. Sci. (Colch.)100(4), 459–465 (2001).
   Google Scholar
• Terres W, Becker P, Rosenberg A. Changes in cardiovascular risk profile during the cessation of smoking. Am. J. Med.97(3), 242–249 (1994).
   PubMed Web of Science ®Google Scholar
• Morita H, Ikeda H, Haramaki N, Eguchi H, Imaizumi T. Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J. Am. Coll. Cardiol.45(4), 589–594 (2005).
   PubMed Web of Science ®Google Scholar
• Eliasson B, Hjalmarson A, Kruse E, Landfeldt B, Westin A. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob. Res.3(3), 249–255 (2001).
   PubMedGoogle Scholar
• Stubbe I, Eskilsson J, Nilsson-Ehle P. High-density lipoprotein concentrations increase after stopping smoking. Br. Med. J. (Clin. Res. Ed.)284(6328), 1511–1513 (1982).
   PubMed Web of Science ®Google Scholar
• Oren S, Isakov I, Golzman B et al. The influence of smoking cessation on hemodynamics and arterial compliance. Angiology57(5), 564–568 (2006).
   PubMed Web of Science ®Google Scholar
• Law MR, Wald NJ. Environmental tobacco smoke and ischemic heart disease. Prog. Cardiovasc. Dis.46(1), 31–38 (2003).
   PubMedGoogle Scholar
• Lightwood J. The economics of smoking and cardiovascular disease. Prog. Cardiovasc. Dis.46(1), 39–78 (2003).
   PubMed Web of Science ®Google Scholar
• Brown AI, Garber AM. A concise review of the cost–effectiveness of coronary heart disease prevention. Med. Clin. North Am.84(1), 279–297 (2000).
   PubMed Web of Science ®Google Scholar
• Prignot J, Bartsch P, Vermeire P et al. Physician’s involvement in the smoking cessation process of their patients. Results of a 1998 survey among 4,643 Belgian physicians. Acta Clin. Belg.55(5), 266–275 (2000).
   PubMed Web of Science ®Google Scholar
• Hasdai D, Garratt KN, Grill DE et al. Predictors of smoking cessation after percutaneous coronary revascularization. Mayo Clin. Proc.73(3), 205–209 (1998).
   PubMedGoogle Scholar
• Holtzman JL, Weeks CE, Kvam DC et al. Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate. Clin. Pharmacol. Ther.46(1), 1–8 (1989).
   PubMedGoogle Scholar
• Walle T, Walle UK, Cowart TD, Conradi EC, Gaffney TE. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites. J. Pharmacol. Exp. Ther.241(3), 928–933 (1987).
   PubMed Web of Science ®Google Scholar
• Nam CM, Oh KW, Lee KH et al. Vitamin C intake and risk of ischemic heart disease in a population with a high prevalence of smoking. J. Am. Coll. Nutr.22(5), 372–378 (2003).
   PubMed Web of Science ®Google Scholar
• Evans RW, Shaten BJ, Day BW, Kuller LH. Prospective association between lipid soluble antioxidants and coronary heart disease in men: the multiple risk factor intervention trial. Am. J. Epidemiol., 147(2), 180–186 (1998).
   PubMed Web of Science ®Google Scholar
• Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet361(9374), 2017–2023 (2003).
   PubMed Web of Science ®Google Scholar
• Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet359(9301), 114–117 (2002).
   PubMed Web of Science ®Google Scholar
• Fiore MC, Jaen CR, Baker TB et al.Treating Tobacco Use and Dependence: 2008 Update. US Department of Health and Human Services. Public Health Service, MD, USA (2008).
   Google Scholar
• Silagy C, Stead L. Physician advice for smoking cessation (Cochrane Review). Cochrane Database Syst. Rev. (2), CD000165 (2001).
   Google Scholar
• Anderson JE, Jorenby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest121(3), 932–941 (2002).
   PubMed Web of Science ®Google Scholar
• Fagerstrom K, Balfour DJK. Neuropharmacology and potential efficacy of new treatments for tobacco dependence. Expert Opin. Investig. Drugs15(2), 107–116 (2006).
   PubMed Web of Science ®Google Scholar
• Balfour D, Benowitz N, Fagerstrom K, Kunze M, Keil U. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report Eur. Heart J.21(6), 438–445 (2000).
   PubMed Web of Science ®Google Scholar
• Stead L, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev.1, CD000146 (2008).
   PubMed Web of Science ®Google Scholar
• Molyneux A, Lewis S, Leivers U et al. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax58(6), 484–488 (2003).
   PubMed Web of Science ®Google Scholar
• McRobbie H, Hajek P. Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addiction96(11), 1547–1551 (2001).
   PubMedGoogle Scholar
• Benowitz NL, Chan K, Denaro CP, Jacob P 3rd. Stable isotope method for studying transdermal drug absorption: the nicotine patch. Clin. Pharmacol. Ther.50(3), 286–293 (1991).
   PubMed Web of Science ®Google Scholar
• Meine TJ, Patel MR, Washam JB, Pappas PA, Jollis JG. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am. J. Cardiol.95(8), 976–978 (2005).
   PubMed Web of Science ®Google Scholar
• McRobbie H. Current insights and new opportunities for smoking cessation. Br. J. Cardiol.12(1), 37–44 (2005).
   Google Scholar
• Royal College of Physicians. Nicotine Addiction in Britain. Royal College of Physicians, London, UK (2000).
   Google Scholar
• Jorenby DE, Leischow SJ, Nides MA et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N. Engl. J. Med.340(9), 685–691 (1999).
   PubMed Web of Science ®Google Scholar
• West R. Bupropion SR for smoking cessation. Expert Opin. Pharmacother.4(4), 533–540 (2003).
   PubMed Web of Science ®Google Scholar
• Tonstad S, Farsang C, Klaene G et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur. Heart J.24(10), 946–955 (2003).
   PubMed Web of Science ®Google Scholar
• Roddy E. Bupropion and other non-nicotine pharmacotherapies. Br. Med. J.328(7438), 509–511 (2004).
   PubMedGoogle Scholar
• Jorenby DE, Hays JT, Rigotti NA et al. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA296(1), 56–63 (2006).
   PubMed Web of Science ®Google Scholar
• Coe JW, Brooks PR, Vetelino MG et al. Varenicline: an α4β2 nicotinic receptor partial agonist for smoking cessation. J. Med. Chem.48(10), 3474–3477 (2005).
   PubMed Web of Science ®Google Scholar
• Nides M. Efficacy and safety of varenicline for smoking cessation. In: 1st UK National Smoking Cessation Conference. London, UK (2005)
   Google Scholar
• Kuehn B. FDA warns of adverse events linked to smoking cessation drug and antiepileptics. JAMA299(10), 1121–1122 (2008).
   PubMed Web of Science ®Google Scholar
• McRobbie H, Lee M, Juniper Z. Non-nicotine pharmacotherapies for smoking cessation. Respir. Med.99(10), 1203–1212 (2005).
   PubMedGoogle Scholar
• Roose SP, Laghrissi-Thode F, Kennedy JS et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA279(4), 287–291 (1998).
   PubMed Web of Science ®Google Scholar
• White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst. Rev.1, CD000009 (2006).
   Google Scholar
• Abbot NC, Stead LF, White AR, Barnes J. Hypnotherapy for smoking cessation. Cochrane Database Syst. Rev.1, 1–15 (2006).
   Google Scholar
• Sargent RP, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. Br. Med. J.328(7446), 977–980 (2004).
   PubMed Web of Science ®Google Scholar
• Bartecchi C, Alsever RN, Nevin-Woods C et al. Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation114(14), 1490–1496 (2006).
   PubMed Web of Science ®Google Scholar
• Khuder SA, Milz S, Jordan T et al. The impact of a smoking ban on hospital admissions for coronary heart disease. Prev. Med.45(1), 3–8 (2007).
   PubMed Web of Science ®Google Scholar
• Barnoya J, Bialous SA, Glantz SA. Effective interventions to reduce smoking-induced heart disease around the world: time to act. Circulation112(4), 456–458 (2005).
   PubMedGoogle Scholar
• Stead LF, Perera R, Lancaster T. A systematic review of interventions for smokers who contact quitlines. Tob. Control16(Suppl. 1), i3–i8 (2007).
   PubMedGoogle Scholar
• Zhu SH, Anderson C, Tedeschi G et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N. Engl. J. Med.347(14), 1087–1093 (2002).
   PubMed Web of Science ®Google Scholar
• Rodgers A, Corbett T, Bramley D et al. Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob. Control14(4), 255–261 (2005).
   PubMed Web of Science ®Google Scholar
• Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst. Rev.3, CD001837 (2007).
   Google Scholar
• Hyland A, Rezaishiraz H, Giovino G et al. Over-the-counter availability of nicotine replacement therapy and smoking cessation. Nicotine Tob. Res.7(4), 547–555 (2005).
   PubMed Web of Science ®Google Scholar
• Waitzkin H. One and a half centuries of forgetting and rediscovering: virchow’s lasting contributions to social medicine. Social Med.1(1), 5–10 (2006).
   Google Scholar
• World Health Organisation. Chapter 5. Building capacity for smoking cessation and treatment of tobacco dependence. In: Policy Recommendations for Smoking Cessation and Treatment of Tobacco Dependence. Silva, VdCe (Ed.). WHO, Geneva, Switzerland (2003).
   Google Scholar
• Bullen C, Whittaker R, McRobbie H, Fagerstrom K. A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease. Prev. Cardiol.10(2 Suppl. 1), 5–9 (2007).
   PubMedGoogle Scholar
• Fagerstrom K, Balfour DJK. Neuropharmacology and potential efficacy of new treatments for tobacco dependence. Expert Opin. Investig. Drugs15(2), 107–116 (2006).
   PubMed Web of Science ®Google Scholar
• Fagerstrom K. New perspectives in the treatment of tobacco dependence. Monaldi Arch. Chest Dis.60(3), 179–183 (2003).
   PubMedGoogle Scholar
• Siu E, Tyndale R. Selegiline is a mechanism-based inactivator of CYP2A6 inhibting nicotine metabolism in humans and mice. J. Pharmacol. Exp. Ther.324, 992–999 (2008).
   PubMed Web of Science ®Google Scholar
• Cahill K, Ussher M. Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. Cochrane Database Syst. Rev. (4), CD005353 (2007).
   Google Scholar
• Etter J-F. Cytisine for smoking cessation: a literature review and a meta-analyis. Arch. Intern. Med.166(15), 1553–1559 (2006).
   PubMed Web of Science ®Google Scholar